Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

'Ultra' Biotherapeutic Characterisation

Rowan Moore at Thermo Fisher Scientific explores how recent technological advances with in-depth characterisation techniques, particularly in UHPLC, can meet practical and regulatory requirements in the biotherapeutic development chain.

Rowan Moore, Thermo Fisher Scientific (April 2016)

Keywords: UHPLC, Characterisation bottleneck, Advanced column chemistries, Separation technologies

    View full article    |    Back to Analytical Laboratory Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |